Polar Asset Management Partners’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-31,731
| Closed | -$117K | – | 1078 |
|
|
2023
Q1 | $117K | Hold |
31,731
| – | – | ﹤0.01% | 629 |
|
|
2022
Q4 | $121K | Hold |
31,731
| – | – | ﹤0.01% | 740 |
|
|
2022
Q3 | $251K | Hold |
31,731
| – | – | ﹤0.01% | 787 |
|
|
2022
Q2 | $666K | Hold |
31,731
| – | – | 0.01% | 736 |
|
|
2022
Q1 | $1.19M | Hold |
31,731
| – | – | 0.01% | 641 |
|
|
2021
Q4 | $1.78M | Hold |
31,731
| – | – | 0.02% | 575 |
|
|
2021
Q3 | $2.29M | Hold |
31,731
| – | – | 0.02% | 485 |
|
|
2021
Q2 | $3.04M | Hold |
31,731
| – | – | 0.03% | 447 |
|
|
2021
Q1 | $4.69M | Buy |
+31,731
| New | +$4.69M | 0.05% | 322 |
|